As a consequence, molecular imaging methods targeting PSMA, namely, PSMA-positron emission tomography (PET), have gained particular interest and diffusion for PCa staging and restaging, especially in high-risk patients (1, 2). The gene discussed is FOLH1; the disease is posterior cortical atrophy.